S. Ross

发表

Heterogenous binding of 3H-remoxipride to membranes of rat liver and brain.

S. Ross, 1995, Pharmacology & toxicology.

Substituted amphetamine derivatives. II. Behavioural effects in mice related to monoaminergic neurones.

S. Ross, S. Ogren, 2009, Acta pharmacologica et toxicologica.

In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299

S. Ross, C. Stenfors, T. Werner, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Studies on the absorption, distribution and metabolism of labelled prilocaine and lidocaine in some animal species.

S. Ross, B. Åkerman, A. Åström, 2009, Acta pharmacologica et toxicologica.

Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.

S. Ross, A. L. Renyi, 1967, European journal of pharmacology.

Stereospecificity of the enzymatic biotransformation of the enantiomers of prilocaine (Citanest).

S. Ross, B. Åkerman, 2009, Acta pharmacologica et toxicologica.

The enzymatic hydrolysis of a series of aminoacylanilides in relation to their nerve blocking effect and toxicity.

S. Ross, A. Telc, S. Åkerman, 2009, Acta pharmacologica et toxicologica.

On the topology of the norepinephrine transport carrier in rat hypothalamus. The site of action of tricyclic uptake inhibitors.

T. de Paulis, S. Ross, D. Kelder, 1978, Molecular pharmacology.

Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs

J. Marcusson, S. Ross, P. Allard, 2005, Psychopharmacology.

Interactions between reserpine and various compounds on the accumulation of [14C] 5-hydroxytryptamine and [3H]noradrenaline in homogenates from rat hypothalamus.

S. Ross, 1979, Biochemical pharmacology.

Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.

S. Ross, D. Kelder, 2009, Acta pharmacologica et toxicologica.

The central stimulatory action of inhibitors of the dopamine uptake.

S. Ross, 1979, Life sciences.

Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

Potentiation by reserpine of the inhibition by amphetamine of [3H]dopamine accumulation in the rat striatum

S. Ross, 1977, The Journal of pharmacy and pharmacology.

Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.

S. Ross, S. Ogren, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.

S. Ross, S. Ogren, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

BLOCKING ACTION OF SYMPATHOMIMETIC AMINES ON THE UPTAKE OF TRITIATED NORADRENALINE BY MOUSE CEREBRAL CORTEX TISSUES IN VITRO.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

IN VIVO INACTIVATION OF CATECHOLAMINES IN MICE.

S. Ross, 2009, Acta pharmacologica et toxicologica.

LONG‐TERM BIOCHEMICAL AND BEHAVIORAL EFFECTS OF p‐CHLOROAMPHETAMINE IN THE RAT

B. Srebro, C. Köhler, S. Ögren, 1978, Annals of the New York Academy of Sciences.

Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population

L. Wetterberg, S. Ross, Y. Floderus, 1981, Clinical genetics.

Counteraction of the rapid tolerance to 8‐OH‐DPAT‐induced corticosterone secretion in rats by activation of the GABAA receptor‐chloride channel complex

S. Ross, D. Kelder, 1993, British journal of pharmacology.

Subchronic treatment of rats with remoxipride fails to modify σ binding sites in the brain

H. Ericson, S. Ross, 1992 .

Low dopamine‐β‐hydroxylase activity in Down's syndrome

L. Wetterberg, K. Gustavson, S. Ross, 1972 .

Proadifen-sensitive high affinity binding of 3H-alaproclate to liver membranes.

S. Ross, 1987, Pharmacology & toxicology.

Inhibition of the uptake of 3-H-dopamine and 14-C-5-hydroxytryptamine in mouse striatum slices.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

α1‐Adrenoceptor function in the rat hippocampus as assessed by noradrenaline‐stimulated inositol phospholipid breakdown after destruction of noradrenergic neurons by neonatal 6‐hydroxydopamine treatment

C. Fowler, S. Ross, B. Minor, 1986, The Journal of pharmacy and pharmacology.

Neuronal transport of 5-hydroxytryptamine.

S. Ross, 1980, Pharmacology.

Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.

S. Ross, 1991, Pharmacology & toxicology.

Further studies on the high-affinity binding of 3H-alaproclate to membranes from rat liver and some other tissues.

S. Ross, 1990, Pharmacology & toxicology.

Uptake of tritiated tyramine and (+)‐amphetamine by mouse heart slices

S. Ross, A. L. Renyi, S. B. Ross, 1966, The Journal of pharmacy and pharmacology.

Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices

S. Ross, I. Fagervall, A. Ask, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

On the mechanism of the accumulation of 3H-bretylium in peripheral sympathetic nerves

S. Ross, T. Gosztonyi, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats.

J. Marcusson, J. Seckl, I. Johansson, 1998, Brain research. Molecular brain research.

Effect of veratridine on the fluxes of 3H-noradrenaline and 3H-bretylium in the rat vas deferens in vitro

S. Ross, D. Kelder, 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.

Release of 3H-noradrenaline from the rat vas deferens under various in vitro conditions.

S. Ross, D. Kelder, 1979, Acta physiologica Scandinavica.

Modulation of neuronal glutamate transporter rEAAC1 mRNA expression in rat brain by amitriptyline.

J. Marcusson, Josefine Andin, S. Ross, 2004, Brain research. Molecular brain research.

Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat.

S. Visser, S. Martinsson, J. Gabrielsson, 2005, European journal of pharmacology.

Failure to detect in vivo inverse agonism of the 5-HT1B receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs

S. Ross, C. Stenfors, 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

Dopamine-beta-hydroxylase in hypertension.

L. Wetterberg, H. Aberg, S. Ross, 2009, Acta medica Scandinavica.

Binding of a specific 5-HT uptake inhibitor, [3H]norzimelidine, to rat brain homogenates.

H. Hall, S. Ross, S. Ogren, 1982, European journal of pharmacology.

Ionic influence on human erythrocyte catechol-O-methyltransferase activity.

J. Sääf, L. Wetterberg, S. Ross, 1981, Biochemical pharmacology.

D1 and D2 dopamine agonist synergism and the nucleus accumbens

D. Jackson, S. Ross, Kuba Dreher, 1987 .

On the long‐lasting inhibitory effect of N‐(2‐chloroethyl)‐N‐ethyl‐2‐bromobenzylamine (DSP 4) on the active uptake of noradrenaline

S. Ross, A. L. Renyi, 1976, The Journal of pharmacy and pharmacology.

Increased dopaminergic and 5‐hydroxytryptaminergic activities in male rat brain following long‐term treatment with anabolic androgenic steroids

I. Thiblin, S. Ross, C. Stenfors, 1999, British journal of pharmacology.

Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.

S. Ross, I. Fagervall, 1986, Biochemical pharmacology.

Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex.

S. Ross, D. Kelder, 1977, Acta physiologica Scandinavica.

Dopamine-β-hydroxylase in human lymph

L. Wetterberg, H. Hansson, H. Aberg, 1974 .

Inhibition of liver phenylalanine and tryptophan hydroxylating enzyme systems in vitro and in vivo.

S. Ross, O. Haljasmaa, 2009, Acta pharmacologica et toxicologica.

Catechol‐O‐Methyl Transferase Inhibitors. In Vitro Inhibition of the Enzyme in Mouse‐Brain Extract

S. Ross, O. Haljasmaa, Ö. Haljasmaa, 2009 .

Antagonism by methylphenidate of the stereotyped behaviour produced by (+)‐amphetamine in reserpinized rats

S. Ross, 1978, The Journal of pharmacy and pharmacology.

Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action.

S. Ross, R. Dahlbom, J. Johansson, 1973, Acta pharmaceutica Suecica.

Serotonin selective reuptake inhibitors — relationship between chemical structure and pharmacological effects

H. Hall, T. Högberg, S. Ögren, 1983 .

Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.

K. Fuxe, C. Köhler, S. Ross, 1981, European Journal of Pharmacology.

Catechol‐O‐methyltransferase activity in erythrocytes in Down's syndrome

L. Wetterberg, K. Gustavson, S. Ross, 1973, Clinical genetics.

Genetic control of plasma dopamine-beta-hydroxylase.

L. Wetterberg, S. Ross, M. Myrhed, 1973, Life sciences.

DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

G. Jonsson, S. Ross, F. Ponzio, 1981, European journal of pharmacology.

Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants onβ-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex

H. Hall, S. Ross, M. Sällemark, 2005, Journal of Neural Transmission.

Pharmacological and toxicological exploitation of amine transporters

S. Ross, 1987 .

A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat Brain

S. Ross, I. Fagervall, Ingrid Fagervall, 1986, Journal of neurochemistry.

DSP4 and behavioural experiments

S. Ross, 1985 .

2810 – A NEW NEUROTOXIC COMPOUND AS DENERVATION TOOL FOR NORADRENALINE NEURONS

G. Jonsson, S. Ross, F. Ponzio, 1978 .

Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine.

S. Ögren, S. Ross, S. Ogren, 1972, European journal of pharmacology.

LONG‐TERM EFFECTS OF N‐2‐CHLOROETHYL‐N‐ETHYL‐2‐BROMOBENZYLAMINE HYDROCHLORIDE ON NORADRENERGIC NEURONES IN THE RAT BRAIN AND HEART

S. Ross, 1976 .

Kinetic aspects of monoamine oxidase activity in twins with psychoses

L. Wahlund, L. Wahlund, J. Sääf, 1981, Clinical genetics.

L. Oreland, H. Perris, C. Perris, 1980, Acta psychiatrica Scandinavica.

Dopamine-beta-hydroxylase and plasma renin activity in twenty hypertensive subjects.

L. Wetterberg, H. Hedstrand, H. Aberg, 1975, Upsala journal of medical sciences.

Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients Biochemical aspects

T. Hällström, S. Ross, D. Kelder, 1986, Acta psychiatrica Scandinavica.

A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat

T. Archer, G. Jonsson, S. Ross, 1984, British journal of pharmacology.

α1 (but not α2)-Adrenoceptor Agonists in Combination with the Dopamine D2 Agonist Quinpirole Produce Locomotor Stimulation in Dopamine-Depleted Mice

D. Jackson, S. Ross, D. Kelder, 1990 .

The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice.

D. Jackson, S. Edwards, S. Ross, 1989, Pharmacology & toxicology.

Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies

D. Jackson, L. Larsson, N. Mohell, 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

5-Hydroxytryptamine depletion and avoidance acquisition in the rat. Antagonism of the long-term effects of p-chloroamphetamine with a selective inhibitor of 5-hydroxytryptamine uptake

B. Srebro, C. Kohler, S. Ögren, 1976, Neuroscience Letters.

Is the sigma opiate receptor a proadifen-sensitive subform of cytochrome P-450?

S. Ross, 1990, Pharmacology & toxicology.

Stereoselective effects of the potentially neuroleptic rigid spiro amines

S. Ross, S. Ogren, N. Stjernström, 1976, Nature.

Distribution of the Two Forms of Monoamine Oxidase Within Monoaminergic Neurons of the Guinea Pig Brain

S. Ross, 1987, Journal of neurochemistry.

Cyclization of three N- -haloalkyl-N-methylaminoaceto-2,6-xylidide derivatives in relation to their local anesthetic effect in vitro and in vivo.

S. Ross, S. Bengt, A. Akerman, 1972, Journal of Pharmacology and Experimental Therapeutics.

Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression

D. Westerlund, S. Ross, A. Åberg-Wistedt, 2004, Psychopharmacology.

Kinetic aspects of human platelet monoamine oxidase thermolability.

L. Wahlund, J. Sääf, L. Wetterberg, 1984, Acta physiologica Scandinavica.

Activation of monoamine oxidase by high molecular weight fractions of human plasma.

L. Wahlund, J. Sääf, L. Wetterberg, 1984, Acta physiologica Scandinavica.

Monoamine oxidase in human platelets. Kinetics and methodological aspects.

J. Sääf, L. Wetterberg, N. Koide, 1981, Biochemical pharmacology.

Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of chronic therapy-resistant schizophrenics before and after hemodialysis therapy.

L. Wetterberg, C. Fowler, S. Ross, 1983, Artificial organs.

Behavioral Pharmacology of AR-A000002, a Novel, Selective 5-Hydroxytryptamine1B Antagonist

T J Hudzik, J. Evenden, C. Ryan, 2003, Journal of Pharmacology and Experimental Therapeutics.

SYNTHESIS OF PYRIDYLALLYLAMINES RELATED TO ZIMELIDINE AND THEIR INHIBITION OF NEURONAL MONOAMINE UPTAKE

S. Ross, A. L. Renyi, T. Hoegberg, 1982 .

Synthesis of pyridylallylamines related to zimelidine and their inhibition of neuronal monoamine uptake.

T. Högberg, S. Ross, A. L. Renyi, 1981, Journal of medicinal chemistry.

C8-substituted derivatives of 2-(dipropylamino)tetralin: Palladium-catalyzed synthesis and interactions with 5-HT1A-receptors

T. Lewander, U. Hacksell, Ye Liu, 1991 .

Synthesis and monoamine oxidase inhibitory activities of alpha-allenic amines in vivo and in vitro. Different activities of two enantiomeric allenes.

S. Ross, I. Fagervall, A. Claesson, 1983, Journal of medicinal chemistry.

Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles.

Y. Kumar, S. Ross, L. Florvall, 1986, Journal of medicinal chemistry.

Measurement of intraneuronal monoamine oxidase in the brain

S. Ross, 1986 .

Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical properties

C. Fowler, S. Ross, 1984, Medicinal research reviews.

On the fate of dopamine-beta-hydroxylase after release from the pheripheral sympathetic nerves in the cat.

S. Ross, H. Eriksson, W. Hellström, 1974, Acta physiologica Scandinavica.

Active transport of 3H-bretylium in the rat vas deferens in vitro.

S. Ross, D. Kelder, 1976, Acta physiologica Scandinavica.

Electrophoretic properties of dopamine -hydroxylase in several tissues from three species.

P. Molinoff, R. Weinshilboum, J. Axelrod, 1972, Molecular pharmacology.

Plasma Dopamine-β-Hydroxylase Activity in Hypertension and Various Neuropsychiatric Disorders

L. Wetterberg, H. Aberg, S. Ross, 1972 .

Low dopamine-beta-hydroxylase activity in Down's syndrome.

L. Wetterberg, K. Gustavson, S. Ross, 1972, Clinical genetics.

Genetic control of plasma dopamine- β -hydroxylase

L. Wetterberg, S. Ross, M. Myrhed, 1973 .

Accumulation of tritiated 5-hydroxytryptamine in brain slices.

S. Ross, A. L. Renyl, 1967, Life sciences.

Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine.

S. Ross, C. Stenfors, 2002, Life sciences.

Inhibition of Monoamine Oxidase Within Monoaminergic Neurons in the Rat Brain by (E)‐β‐Fluoromethylene‐m‐Tyrosine (MDL 72394)

S. Ross, I. Fagervall, Ingrid Fagervall, 1989, Journal of neurochemistry.

The effect of acute zimeldine and alaproclate administration on the acquisition of two-way active avoidance: Comparison with other antidepressant agents, test of selectivity and sub-chronic studies

T. Archer, S. Ögren, S. Ross, 2004, Psychopharmacology.

Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues

S. B. Ross, Anna L. Renyi, S. Ross, 1977, Neuropharmacology.

Long-term effects of N-hydroxy-4-chloroamphetamine on the level and accumulation of 5-hydroxytryptamine in the rat brain.

S. Ross, A. L. Renyi, T. Gosztonyi, 1974, European journal of pharmacology.

The inhibition of the cage-leaving response—A model for studies of the serotonergic neurotransmission in the rat

T. Archer, A. Fredriksson, S. Ross, 2005, Journal of Neural Transmission.

5-Hydroxytryptamine and avoidance performance in the rat. Antagonism of the acute effect of p-chloroamphetamine by zimelidine, an inhibitor of 5-hydroxytryptamine uptake

A. Holm, S. Ögren, S. Ross, 1978, Neuroscience Letters.

Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake.

S. Ross, 2009, Acta pharmacologica et toxicologica.

On the mechanism of the acute decrease of rat brain tryptophan hydroxylase activity by 4-chloroamphetamine

S. Ross, Ö. Frödén, 1977, Neuroscience Letters.

T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4

T. Archer, A. Mohammed, S. Ross, 1983, Pharmacology Biochemistry and Behavior.

Central noradrenaline depletion antagonizes aspects ofd-amphetamine-induced hyperactivity in the rat

T. Lewander, T. Archer, A. Mohammed, 2004, Psychopharmacology.

Inhibition of choline acetyltransferase by 2-dimethylaminoethyl chloroacetate and related compounds.

S. Ross, L. Florvall, O. Frödén, 2009, Acta pharmacologica et toxicologica.

[3H]Desipramine Binding to Rat Brain Tissue: Binding to Both Noradrenaline Uptake Sites and Sites Not Related to Noradrenaline Neurons

J. Marcusson, S. Ross, I. Bäckström, 1989, Journal of neurochemistry.

Acute effects of zimelidine and alaproclate, two inhibitors of serotonin uptake, on neuroendocrine function

P. Eneroth, E. Syvälahti, S. Ross, 1979, Psychiatry Research.

The pharmacology of zimelidine: A 5‐HT selective reuptake inhibitor

H. Hall, A. Holm, S. Ögren, 1981, Acta psychiatrica Scandinavica. Supplementum.

Effects of zimelidine on various transmitter systems in the brain.

H. Hall, S. Ross, S. Ogren, 1982, Advances in biochemical psychopharmacology.

(R)-(+)-2-[[[3-(Morpholinomethyl)-2H-chromen-8-yl]oxy]methyl] morpholine methanesulfonate: a new selective rat 5-hydroxytryptamine1B receptor antagonist.

L. Larsson, S. Ross, S. Berg, 1998, Journal of medicinal chemistry.

Evidence for involvement of protein kinases in the regulation of serotonin synthesis and turnover in the mouse brain in vivo

S. Ross, C. Stenfors, 2002, Journal of Neural Transmission.

Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram

S. Ross, C. Stenfors, H. Yu, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain

Hong Yu, S. Ross, C. Stenfors, 2000, Neuropharmacology.

Differential sensitivity to 8-hydroxy-2-(di-n-propylamino)tetralin-induced corticosterone secretion and hypothermia between Sprague-Dawley rats from different breeding colonies.

S. Ross, D. Kelder, 2001, Pharmacology & toxicology.

The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.

J. Evenden, L. Larsson, C. Fowler, 2001, Journal of Pharmacology and Experimental Therapeutics.

On the mode of action of central stimulatory agents.

S. Ross, 2009, Acta pharmacologica et toxicologica.

Cortical beta- and alpha 2- adrenoceptor binding, hypothalamic noradrenaline and pineal melatonin concentrations measured at different times of the day after repeated treatment of rats with imipramine, zimeldine, alaproclate and amiflamine.

J. Sääf, H. Hall, C. Fowler, 2009, Acta pharmacologica et toxicologica.

Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat

J. Marcusson, J. Seckl, I. Johansson, 2000, Psychopharmacology.

Evoked efflux of 3H-bretylium by sympathomimetic amines from the rat vas deferens in vitro.

S. Ross, D. Kelder, 2009, Acta pharmacologica et toxicologica.

A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices.

S. Ögren, S. Ross, S. Ogren, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue.

S. Ross, A. L. Renyi, 1969, European journal of pharmacology.

CATECHOL-O-METHYL TRANSFERASE INHIBITORS. IN VIVO INHIBITION IN MICE.

S. Ross, O. Haljasmaa, Ö. Haljasmaa, 2009 .

Pharmacokinetics of haloalkylamines: cyclization and distribution in blood in vitro and in vivo

S. Ross, 1975, The Journal of pharmacy and pharmacology.

Cyclizing compounds. 3. Local anesthetic action of N-(omega-haloalkyl)-N-methylaminoaceto-2,6-xylidides.

S. Ross, R. Sandberg, B. Akerman, 1973, Journal of medicinal chemistry.

(+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.

S. Ross, A. Ask, K. Högberg, 1982, Biochemical pharmacology.

Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.

S. Ross, S. Ogren, L. Florvall, 1978, Journal of medicinal chemistry.

Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alpha-amino acid esters of phenethyl alcohols.

S O Ogren, U H Lindberg, S O Thorberg, 1978, Journal of medicinal chemistry.

Inhibition of [3H]paroxetine binding by various serotonin uptake inhibitors: structure-activity relationships.

J. Marcusson, T. Högberg, U. Norinder, 1992, European journal of pharmacology.

[3H] GBR‐12935 Binding to Cytochrome P450 in the Human Brain

J. Marcusson, S. Ross, P. Allard, 1994, Journal of neurochemistry.

Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.

S. Ross, L. Rényi, 2009, Acta pharmacologica et toxicologica.

GENETICS AND BIOCHEMISTRY OF SCHIZOPHRENIA IN A DEFINED POPULATION

L. Wetterberg, S. Ross, J. Böök, 1979 .

Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project

L. Wetterberg, S. Ross, Kiyofumi Kobayashi, 1979, Clinical genetics.

Kinetics and Thermolability of Platelet Monoamine Oxidase in Cluster Headache and Migraine

L. Wahlund, J. Sääf, L. Wetterberg, 1984, Cephalalgia : an international journal of headache.

The motor effects of bromocriptine — a review

D. Jackson, S. Ross, O. Jenkins, 2004, Psychopharmacology.

Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.

G. Sedvall, G. Oxenstierna, G. Edman, 1986, Journal of psychiatric research.

(S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.

N. Andén, U. Hacksell, Y. Li, 1990, Journal of medicinal chemistry.

Psychoses in twins A 10 year clinical and biochemical follow-up study

J. Sääf, L. Wetterberg, S. Ross, 1989, Schizophrenia Research.

Structural Requirements for Uptake into Serotoninergic Neurones

S. Ross, A. Ask, S. B. Ross, 2009 .

Concentration and Uptake of 5-Hydroxytryptamine in Platelets from Cluster Headache and Migraine Patients

J. Sääf, L. Wetterberg, E. Waldenlind, 1985, Cephalalgia : an international journal of headache.

Serum dopamine-beta-hydroxylase in affective disorders.

L. Wetterberg, C. Perris, S. Ross, 1978, Neuropsychobiology.

Catechol-O-methyltransferase activity in human erythrocytes: methodological aspects.

J. Sääf, L. Wetterberg, S. Ross, 1981, Upsala journal of medical sciences.

Characterization of [3H]Paroxetine Binding in Rat Brain

J. Marcusson, S. Ross, K. Eriksson, 1988, Journal of neurochemistry.

Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets

Svante B. Ross, J. Marcusson, Jan O. Marcusson, 2005, Psychopharmacology.

Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.

J. Marcusson, S. Ross, I. Bäckström, 1986, Molecular pharmacology.

Evidence for a role of the locus coeruleus noradrenaline system in learning

T. Archer, S. Ögren, S. Ross, 1980, Neuroscience Letters.

Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism

Svante B. Ross, S. Ross, 1991, Journal of neurochemistry.

DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action

S. Ross, C. Stenfors, 2014, Neurotoxicity Research.

DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action

S. Ross, C. Stenfors, 2014, Neurotoxicity Research.

The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

D. Jackson, L. Larsson, E. Jerning, 1997, The Journal of pharmacology and experimental therapeutics.

Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT

S. Ross, B. Svensson, L. Rényi, 1990, Neuropharmacology.

Active uptake of tritiated metaraminol by mouse brain slices in vitro.

S. Ross, A. L. Renyi, 1966, Life sciences.

Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.

H. Ericson, S. Ross, 1992, European journal of pharmacology.

Biochemical and behavioural effects of isamoltane, a β-adrenoceptor antagonist with affinity for the 5-HT1B receptor of rat brain

L. Larsson, S. Ross, S. Berg, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Development of tolerance to 8-OH-DPAT induced blockade of acquisition of a passive avoidance response

D. Jackson, S. Ross, A. Bengtsson, 1994, Neuropharmacology.

Active and passive avoidance performances following bilateral olfactory bulbectomy.

T. Archer, A. Mohammed, A. Fredriksson, 1984, Scandinavian journal of psychology.

Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat

D. Westerlund, H. Hall, S. Ross, 2004, Psychopharmacology.

Serotonin involvement in aversive conditioning: Reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine

T. Archer, S. Ögren, S. Ross, 1982, Neuroscience Letters.

Catecholaminergic activity in idiopathic torsion dystonia

L. Wetterberg, A. Yuwiler, S. Ross, 1987, Neurology.

Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse

D. Jackson, S. Edwards, S. Ross, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

Anti‐aggressive action of dopamine‐β‐hydroxylase inhibitors in mice

S. Ögren, S. Ross, 1976 .

Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function

D. Jackson, L. Larsson, S. Ross, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002

Lars-Gunnar Larsson, Svante B. Ross, L. Larsson, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo

L. Larsson, S. Ross, H. Yu, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.

L. Larsson, S. Ross, C. Stenfors, 1998, European journal of pharmacology.

Anti-aggressive effect of zimelidine in isolated mice.

A. Holm, S. Ross, S. Ogren, 2009, Acta pharmacologica et toxicologica.

EFFECTS OF VARIOUS COMPOUNDS ON ADRENERGIC MECHANISMS RECORDED BY CHANGES IN HEART RATES OF ANESTHETISED MICE.

S. Ross, 2009, Acta pharmacologica et toxicologica.

Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo

L. Wetterberg, S. Ross, J. Beck-friis, 2004, Psychopharmacology.

Attenuation of the post-decapitation convulsions after repeated treatment of rats with desipramine, imipramine and maprotiline.

T. Archer, S. Ross, B. Minor, 2009, Acta pharmacologica et toxicologica.

Antagonism of 5‐methoxy‐N,N‐dimethyltryptamine‐induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5‐hydroxytryptamine neurotransmission

T. Archer, S. Ross, Bengt Tandberg, 1985, The Journal of pharmacy and pharmacology.

Localization and Inhibition of Monoamine Oxidase

J. Sullivan, K. Tipton, L. Oreland, 1988 .

Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones

S. Ross, L. Florvall, I. Fagervall, 1986, Neuropharmacology.

Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine.

T. Archer, G. Jonsson, S. Ross, 1985, Behavioral and neural biology.

Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment

J. Marcusson, S. Ross, I. Bäckström, 2004, Psychopharmacology.

Homoallylic amines related to zimeldine. A comparative study on neuronal serotonin and norepinephrine reuptake based on conformational analysis.

J. Bunce, T. Högberg, P. Ström, 1988, Journal of medicinal chemistry.

On the role of the dorsal mesencephalic tegmentum in the control of masculine sexual behavior in the rat: Effects of electrolytic lesions, ibotenic acid and DSP4

C. Köhler, S. Ross, S. Hansen, 1982, Brain Research.

DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral noradrenaline depletion

T. Archer, S. Ögren, S. Ross, 2004, Psychopharmacology.

Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release

S. Ross, C. Stenfors, 2004, Psychopharmacology.

A double‐blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression

S. Ross, A. Åberg-Wistedt, B. Sjöquist, 1982, Acta psychiatrica Scandinavica.

Role of descending monoaminergic neurons in the control o sexual behavior: Effects of intrathecal infusions of 6-hydroxydopamine and 5,7-dihydroxytryptamine

S. Ross, S. Hansen, 1983, Brain Research.

INHIBITORS OF THE ENZYMATIC HYDROXYLATION OF PHENYLALANINE AND TRYPTOPHAN BY RAT LIVER EXTRACT IN VITRO.

S. Ross, O. Haljasmaa, 1964, Life sciences.

Selective inhibition of the a form of monoamine oxidase by 4-dimethylamino-α-methylphenylalkylamine derivatives in the rat

S. Ögren, S. Ross, A. Ask, 1982, Neuropharmacology.

Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.

S. Ross, A. L. Renyi, S. B. Ross, 2009, Acta pharmacologica et toxicologica.

Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain

S. Ross, I. Fagervall, A. Ask, 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.

Retention deficits induced by acute p-chloroamphetamine following fear conditioning in the rat

T. Archer, S. Ögren, S. Ross, 1983, Psychopharmacology.

Role of olfactory bulbectomy and DSP4 treatment in avoidance learning in the rat.

T. Archer, G. Jonsson, S. Ross, 1984, Behavioral neuroscience.

Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice

D. Jackson, S. Ross, M. Hashizume, 2004, Psychopharmacology.

Decreased blood level of 5-dehydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake.

L. Wetterberg, S. Ross, B. Fyrö, 1976, Life sciences.

INHIBITORS OF NEURONAL MONOAMINE UPTAKE. III. SYNTHESIS AND PHARMACOLOGIC SCREENING OF ALAPROCLATE ANALOGS

S. Ross, A. L. Renyi, L. Johansson, 1982 .

Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment

S. Ross, A. Åberg-Wistedt, A. Åberg‐Wistedt, 2004, Psychopharmacology.

Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action.

S. Ross, L. Florvall, I. Fagervall, 1986, Journal of medicinal chemistry.

Forebrain projections of the ventral tegmentum as studied by axonal transport of [3H]dopamine in the rat

C. Köhler, L. Haglund, S. Ross, 1979, Neuroscience Letters.

Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine

Lynn P. Martin, D. Jackson, L. Larsson, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis of [3H]proadifen for studying binding to liver membranes

S. Ross, T. Werner, L. Gawell, 1993 .

N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride (DSP4), a new selective noradrenaline neurotoxin, and taste neophobia in the rat

T. Archer, S. Ögren, S. Ross, 1981 .

Clenbuterol, a Central β‐Adrenoceptor Agonist

H. Hall, S. Ross, M. Sällemark, 2009 .

Antagonism of reserpine-induced hypothermia in mice by some beta-adrenoceptor agonists.

S. Ross, 2009, Acta pharmacologica et toxicologica.

Clenbuterol, a central beta-adrenoceptor agonist.

H. Hall, S. Ross, M. Sällemark, 1980, Acta pharmacologica et toxicologica.

Plasma dopamine β‐hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia

L. Wetterberg, S. Ross, J. Böök, 1981 .

Uptake and metabolism of β‐phenethylamine and tyramine in mouse brain and heart slices

S. Ross, A. L. Renyi, S. B. Ross, 1971, The Journal of pharmacy and pharmacology.

Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.

L. Wetterberg, H. Hedstrand, H. Aberg, 1975, International journal of clinical pharmacology and biopharmacy.

Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo

Svante B. Ross, D. Jackson, David M. Jackson, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3H]WIN 35,428 binding in the human brain

J. Marcusson, S. Ross, P. Allard, 1996, Brain Research.

Catechol‐O‐methyltransferase activity in erythrocytes in Down's syndrome: family studies

L. Wetterberg, K. Gustavson, S. Ross, 1982, Clinical genetics.

[3H]GBR-12935 binding to dopamine uptake sites in rat striatum.

J. Marcusson, S. Ross, P. Allard, 1990, Neuropsychobiology.

Robalzotan (NAD‐299), a Novel Selective 5‐HT 1A Receptor Antagonist

E. Jerning, N. Mohell, S. Ross, 2006 .

In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.

C. Ahlgren, Charlotte Ahlgren, Anders Eriksson, 2004, European journal of pharmacology.

N-Methyl-D-aspartate receptor antagonists counteract the long lasting 5-HT1A receptor-induced attenuation of postsynaptic responses in the rat in vivo

S. Ross, D. Kelder, L. Rényi, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

In vitro inhibition of noradrenaline-3H uptake by reserpine and tetrabenazine in mouse cerebral cortex tissues.

S. Ross, A. L. Renyi, 2009, Acta pharmacologica et toxicologica.

Formation of a piperidinium derivative from N-(5'-chloropentyl)-N-methylaminoaceto-2,6-xylidide in relation to the sustained local anaesthetic action on the sciatic nerve of the guinea-pig in vivo.

S. Ross, S. Åkerman, 1971, Nature: New biology.

Selective inhibition by 4,α-dimethyl-m-tyramine (H77/77) and 4-methyl-α-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain

S. Ross, D. Kelder, I. Fagervall, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

Maximal turnover number of the membranal serotonin carrier in rat brain synaptosomes in vitro.

H. Hall, S. Ross, 1983, Acta physiologica Scandinavica.

Antidepressant agents. 1. Chemistry and pharmacology of amino-substituted spiro(5H-dibenzo(a,d)cycloheptene-5,1'-cycloalkanes).

T. de Paulis, S. Ross, S. Ogren, 1974, Journal of medicinal chemistry.

Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.

S. Ross, D. Kelder, I. Fagervall, 1984, Biochemical pharmacology.

Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs

L. Larsson, C. Ahlgren, Hong Yu, 2004, Psychopharmacology.

AR-A000002, a high affinity 5-HT1B receptor antagonist: Pharmacological characterisation

L. Larsson, S. Ross, C. Stenfors, 2001, European Neuropsychopharmacology.